#P01

P1: Anatomy of a False Claims Act Case Katherine Lauer, Partner, Latham & Watkins, LLP Madeline Bainer, Senior Counsel, HHS-OIG Colin Huntley, Assistant Director, Commercial Litigation Branch, Fraud Section, Civil Division, U.S. DOJ View Description

• The Investigation Phase: subpoenas/ CIDs, data analysis, witness interviews and more
• The Negotiation Phase: initiation, ADR, scope of release, monetary and other issues
• The Resolution Phase: settlement agreements, individual liability, CIAs/ OIG and relator issues

General Compliance

#P02

P2: Corporate Integrity Agreements: The Role of an Independent Review Organization (IRO) Steven Ortquist, Founder & Principal, Arete Compliance Solutions, LLC Glennon Moyers, Partner, KPMG LLP Amanda Copsey, ACRB Senior Counsel, Office of the Inspector General, US Department of Health and Human Services View Description

• Why do CIAs include an IRO? Frequently utilized review requirements
• How have the roles and obligations of IRO been modified in recent years? What is behind the modifications?
• Working with your IRO: Keys to a Successful IRO engagement

General Compliance

#P03

P3: Navigating Enforcement Action, Investigations, and Settlements Anne Daly, Chief Compliance & Integrity Officer, Ann & Robert H. Lurie Children's Hospital of Chicago Christina Villa, Compliance Coordinator, Adventist Health Ana-Cristina Navarro, Chief Compliance Officer, HealthRIGHT360 View Description

• This session will provide an overview, through a case study, of how an organization can have an adverse event lead them down the path of government surveys and formal enforcement actions on multiple levels, including a 195 item Systems Improvement Agree
• Illustrate how a compliance team can, and should, assist in facilitating the planning and actions needed to not only overhaul a Health Care Organization’s (HCO) policies and training, but also to support the change in culture needed to sustain
• Provide tools and methods for supporting the organization wide efforts, as well as lessons learned and mechanisms to help prevent your organization from having to navigate the choppy waters of a formal enforcement action

General Compliance

#P04

P4: Litigating a False Claims Act Case John Boese, Of Counsel, Fried, Frank, Harris, Shriver & Jacobson LLP Robert Vogel, Partner, Vogel, Slade & Goldstein, LLP Latour "LT" Lafferty, Partner, Holland & Knight Patrick Klein, Senior Trial Counsel, Department of Justice View Description

• Common motions in FCA litigation
• Proving/disproving falsity, knowledge and damages after Escobar
• Discovery and trial issues in intervened vs. non-intervened cases
• Escobar-related discovery from the government regarding claims payment

General Compliance

#P05

P5: Anti-Kickback Developments Tony Maida, Partner, McDermott Will & Emery Sally Molloy, Chief, Strategy, Policy and Training Unit, U.S. Department of Justice, Criminal Division, Fraud Section Jillian Sparks, Senior Counsel, Industry Guidance Branch, U.S. Department of Health and Human Services, Office of Counsel to the Inspector General View Description

<

ul>